BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15305183)

  • 1. Characterisation of human kallikrein 6/protease M expression in ovarian cancer.
    Ni X; Zhang W; Huang KC; Wang Y; Ng SK; Mok SC; Berkowitz RS; Ng SW
    Br J Cancer; 2004 Aug; 91(4):725-31. PubMed ID: 15305183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative analysis of human kallikrein gene 14 expression in breast tumours indicates association with poor prognosis.
    Yousef GM; Borgoño CA; Scorilas A; Ponzone R; Biglia N; Iskander L; Polymeris ME; Roagna R; Sismondi P; Diamandis EP
    Br J Cancer; 2002 Nov; 87(11):1287-93. PubMed ID: 12439719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human kallikrein 6 (zyme/protease M/neurosin): a new serum biomarker of ovarian carcinoma.
    Diamandis EP; Yousef GM; Soosaipillai AR; Bunting P
    Clin Biochem; 2000 Oct; 33(7):579-83. PubMed ID: 11124344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human kallikrein 6: a new potential serum biomarker for uterine serous papillary cancer.
    Santin AD; Diamandis EP; Bellone S; Soosaipillai A; Cane S; Palmieri M; Burnett A; Roman JJ; Pecorelli S
    Clin Cancer Res; 2005 May; 11(9):3320-5. PubMed ID: 15867230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunofluorometric assay of human kallikrein 6 (zyme/protease M/neurosin) and preliminary clinical applications.
    Diamandis EP; Yousef GM; Soosaipillai AR; Grass L; Porter A; Little S; Sotiropoulou G
    Clin Biochem; 2000 Jul; 33(5):369-75. PubMed ID: 11018688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic marker.
    Yousef GM; Kyriakopoulou LG; Scorilas A; Fracchioli S; Ghiringhello B; Zarghooni M; Chang A; Diamandis M; Giardina G; Hartwick WJ; Richiardi G; Massobrio M; Diamandis EP; Katsaros D
    Cancer Res; 2001 Nov; 61(21):7811-8. PubMed ID: 11691797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarker.
    Hoffman BR; Katsaros D; Scorilas A; Diamandis P; Fracchioli S; Rigault de la Longrais IA; Colgan T; Puopolo M; Giardina G; Massobrio M; Diamandis EP
    Br J Cancer; 2002 Sep; 87(7):763-71. PubMed ID: 12232761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human kallikrein 6 (hK6): a new potential serum biomarker for diagnosis and prognosis of ovarian carcinoma.
    Diamandis EP; Scorilas A; Fracchioli S; Van Gramberen M; De Bruijn H; Henrik A; Soosaipillai A; Grass L; Yousef GM; Stenman UH; Massobrio M; Van Der Zee AG; Vergote I; Katsaros D
    J Clin Oncol; 2003 Mar; 21(6):1035-43. PubMed ID: 12637468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The spectrum of human kallikrein 6 (zyme/protease M/neurosin) expression in human tissues as assessed by immunohistochemistry.
    Petraki CD; Karavana VN; Skoufogiannis PT; Little SP; Howarth DJ; Yousef GM; Diamandis EP
    J Histochem Cytochem; 2001 Nov; 49(11):1431-41. PubMed ID: 11668196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human kallikrein 6 degrades extracellular matrix proteins and may enhance the metastatic potential of tumour cells.
    Ghosh MC; Grass L; Soosaipillai A; Sotiropoulou G; Diamandis EP
    Tumour Biol; 2004; 25(4):193-9. PubMed ID: 15557757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy.
    Bignotti E; Tassi RA; Calza S; Ravaggi A; Romani C; Rossi E; Falchetti M; Odicino FE; Pecorelli S; Santin AD
    Gynecol Oncol; 2006 Nov; 103(2):405-16. PubMed ID: 16725184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation of hK6 expression with clinicopathological features and prognosis in epithelial ovarian cancer].
    Hu CJ; Zhang F; Chen YJ; Sun XM; Zheng JF
    Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):520-3. PubMed ID: 19950700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human kallikrein 8 (hK8/TADG-14) expression is associated with an early clinical stage and favorable prognosis in ovarian cancer.
    Shigemasa K; Tian X; Gu L; Tanimoto H; Underwood LJ; O'Brien TJ; Ohama K
    Oncol Rep; 2004 Jun; 11(6):1153-9. PubMed ID: 15138549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of kallikrein 10 in epithelial ovarian carcinomas.
    Shvartsman HS; Lu KH; Lee J; Lillie J; Deavers MT; Clifford S; Wolf JK; Mills GB; Bast RC; Gershenson DM; Schmandt R
    Gynecol Oncol; 2003 Jul; 90(1):44-50. PubMed ID: 12821340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of a human kallikrein 5 (KLK5) splice variant in ovarian and prostate cancer.
    Kurlender L; Yousef GM; Memari N; Robb JD; Michael IP; Borgoño C; Katsaros D; Stephan C; Jung K; Diamandis EP
    Tumour Biol; 2004; 25(3):149-56. PubMed ID: 15361712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional upregulation of human tissue kallikrein 6 in ovarian cancer: clinical and mechanistic aspects.
    Shan SJ; Scorilas A; Katsaros D; Diamandis EP
    Br J Cancer; 2007 Jan; 96(2):362-72. PubMed ID: 17242704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer.
    Kim H; Scorilas A; Katsaros D; Yousef GM; Massobrio M; Fracchioli S; Piccinno R; Gordini G; Diamandis EP
    Br J Cancer; 2001 Mar; 84(5):643-50. PubMed ID: 11237385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of the human kallikrein gene 14 (KLK14) in normal and cancerous prostatic tissues.
    Yousef GM; Stephan C; Scorilas A; Ellatif MA; Jung K; Kristiansen G; Jung M; Polymeris ME; Diamandis EP
    Prostate; 2003 Sep; 56(4):287-92. PubMed ID: 12858357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas.
    Dong Y; Kaushal A; Bui L; Chu S; Fuller PJ; Nicklin J; Samaratunga H; Clements JA
    Clin Cancer Res; 2001 Aug; 7(8):2363-71. PubMed ID: 11489814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic implications of the immunohistochemical expression of human kallikreins 5, 6, 10 and 11 in renal cell carcinoma.
    Petraki CD; Gregorakis AK; Vaslamatzis MM; Papanastasiou PA; Yousef GM; Levesque MA; Diamandis EP
    Tumour Biol; 2006; 27(1):1-7. PubMed ID: 16340244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.